Ricevi le ultime notizie sulle azioni Cerus con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di CERS

Ultime notizie per

Cerus

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Cerus Corp

Press Releases

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Cerus Corporation Celebrates World Blood Donor Day 2025

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Cerus Corporation Announces Second Quarter 2025 Financial Results

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

CERS

Alcon

Align Technology

Avanos Medical

Bausch & Lomb

Bioventus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Lantheus Holdings

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

RxSight

Sanara MedTech

Solventum

Staar Surgical

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

VolitionRX

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

Cantor Fitzgerald

Stifel

Craig-Hallum

Stephens & Co.

Comments

Cerus Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO